Poseida Therapeutics Inc (PSTX)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.86
+0.13
(+4.76%)
After-Hours: 20:00
Poseida Therapeutics Price to Book Value: 3.051 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 3.051 |
| November 21, 2024 | 3.029 |
| November 20, 2024 | 3.040 |
| November 19, 2024 | 3.096 |
| November 18, 2024 | 2.984 |
| November 15, 2024 | 3.084 |
| November 14, 2024 | 3.587 |
| November 13, 2024 | 3.666 |
| November 12, 2024 | 4.124 |
| November 11, 2024 | 4.146 |
| November 08, 2024 | 3.442 |
| November 07, 2024 | 3.274 |
| November 06, 2024 | 3.107 |
| November 05, 2024 | 2.973 |
| November 04, 2024 | 2.828 |
| November 01, 2024 | 2.760 |
| October 31, 2024 | 2.647 |
| October 30, 2024 | 2.658 |
| October 29, 2024 | 2.737 |
| October 28, 2024 | 2.770 |
| October 25, 2024 | 2.692 |
| October 24, 2024 | 2.703 |
| October 23, 2024 | 2.792 |
| October 22, 2024 | 2.792 |
| October 21, 2024 | 2.792 |
| Date | Value |
|---|---|
| October 18, 2024 | 2.737 |
| October 17, 2024 | 2.837 |
| October 16, 2024 | 2.837 |
| October 15, 2024 | 2.837 |
| October 14, 2024 | 2.792 |
| October 11, 2024 | 2.804 |
| October 10, 2024 | 2.759 |
| October 09, 2024 | 2.859 |
| October 08, 2024 | 2.871 |
| October 07, 2024 | 2.971 |
| October 04, 2024 | 2.915 |
| October 03, 2024 | 2.837 |
| October 02, 2024 | 2.949 |
| October 01, 2024 | 3.072 |
| September 30, 2024 | 3.194 |
| September 27, 2024 | 4.632 |
| September 26, 2024 | 4.744 |
| September 25, 2024 | 4.792 |
| September 24, 2024 | 4.919 |
| September 23, 2024 | 4.935 |
| September 20, 2024 | 5.382 |
| September 19, 2024 | 5.766 |
| September 18, 2024 | 5.606 |
| September 17, 2024 | 5.398 |
| September 16, 2024 | 4.792 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9142
Minimum
Jun 29 2023
6.452
Maximum
Jul 30 2024
2.561
Average
2.456
Median
Feb 18 2021
Price to Book Value Benchmarks
| Organogenesis Holdings Inc | 1.928 |
| MaxCyte Inc | 1.756 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.360 |
Price to Book Value Related Metrics
| PS Ratio | 1.751 |
| Price | 2.73 |
| Earnings Yield | -22.71% |
| Market Cap | 266.08M |